First FDA Approval Agnostic of Cancer Site - When a Biomarker Defines the Indication
- PMID: 29020592
- DOI: 10.1056/NEJMp1709968
First FDA Approval Agnostic of Cancer Site - When a Biomarker Defines the Indication
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials